ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,772Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 617

$460K Total Retail Price of All Prescriptions

Rank: 119 out of 617

443 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 443 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 443 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 8,671 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 494 453 1 4
OMEPRAZOLE 376 344 2 3
METOPROLOL TARTRATE 296 275 3 11
WARFARIN SODIUM 293 258 4 7
LEVOTHYROXINE SODIUM 283 283 5 1
SIMVASTATIN 276 229 6 2
TRAMADOL HCL 261 254 7 15
AMLODIPINE BESYLATE 245 220 8 6
LISINOPRIL 207 178 9 5
POTASSIUM CHLORIDE 191 184 10 10
POLYETHYLENE GLYCOL 3350 190 181 11 32
GABAPENTIN 177 152 12 16
HYDROCODONE-ACETAMINOPHEN 170 141 S3 13 8
CARVEDILOL 153 142 14 19
LANTUS 153 150 14 39
CITALOPRAM HBR 146 142 16 18
FAMOTIDINE 133 109 17 54
SERTRALINE HCL 113 113 18 20
TRAZODONE HCL 110 95 19 51
METOPROLOL SUCCINATE 107 105 20 12
TAMSULOSIN HCL 102 96 21 26
MELOXICAM 95 87 22 24
NOVOLOG 93 90 23 137
SPIRONOLACTONE 93 83 23 42
PANTOPRAZOLE SODIUM 88 84 25 37
NAMENDA 87 83 26 35
PREDNISONE 85 75 27 31
METFORMIN HCL 84 74 28 9
LOSARTAN POTASSIUM 76 75 29 22
ESCITALOPRAM OXALATE 75 74 30 65
CYMBALTA 74 73 31 49
MIRTAZAPINE 73 72 32 50
RISPERIDONE 66 64 33 71
CARBAMAZEPINE 66 53 33 185
METHENAMINE HIPPURATE 66 57 33 273
DIOVAN 65 65 36 41
ZOLPIDEM TARTRATE 65 64 36 23
LEVEMIR 64 64 38 219
ATENOLOL 64 56 38 17
DONEPEZIL HCL 63 59 40 30
ATORVASTATIN CALCIUM 63 44 40 14
AGGRENOX 60 60 42 155
OXYBUTYNIN CHLORIDE 58 58 43 88
HYDROCHLOROTHIAZIDE 57 50 44 13
BACLOFEN 57 26 44 146
QUETIAPINE FUMARATE 54 54 46 78
CLONIDINE HCL 53 52 47 55
HYDROXYZINE HCL 50 50 R 48 206
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.